NASDAQ:GTBP
GT Biopharma, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.gtbiopharma.comipo date
Mar 27, 2018
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I/II clinical tria...Show More
Earnings
Earnings Release in 9 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus